- Home
- ULH vs HQL Comparison
ULH vs HQL Comparison
Compare ULH & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ULH | HQL |
|---|---|---|
| Founded | 1932 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.1M | 490.5M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | ULH | HQL |
|---|---|---|
| Price | $23.04 | $17.22 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 48.1K | ★ 108.6K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | 1.95% | ★ 11.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | ★ $1,461,708,000.00 | N/A |
| Revenue This Year | $4.02 | N/A |
| Revenue Next Year | $3.02 | N/A |
| P/E Ratio | ★ N/A | $21.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.78 | $10.82 |
| 52 Week High | $30.76 | $17.80 |
Technical Indicators
Market Signals| Indicator | ULH | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 68.36 | 60.91 |
| Support Level | $14.23 | $16.40 |
| Resistance Level | $25.67 | $17.40 |
| Average True Range (ATR) | 1.69 | 0.35 |
| MACD | 0.31 | 0.11 |
| Stochastic Oscillator | 92.49 | 86.80 |
Price Performance
Historical ComparisonAbout ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.